Herpes Drug Found Effective but May Cause Anemia; CBCD Reviews the Medical Evidence
Industry: Health & Fitness
Individuals who took a new drug against genital herpes had fewer outbreaks, but experienced side effects. (1) The CBCD reviews the evidence.
New York (PRUnderground) September 28th, 2014
An experimental drug against genital herpes is better than the leading drug on the market according to a new study from the University of Washington and Fred Hutchinson Cancer Research Center in Seattle. (1) The new drug “reduced the rates of genital herpes simplex virus (HSV-2) in a dose-dependent manner in a proof-of-concept trial involving otherwise healthy men and women infected by HSV-2.” (2) AiCuris, the German pharmaceutical company that makes pritelivir, recognized the need for a more effective drug against the herpes virus. Unfortunately, tests also showed that Pritelivir caused dangerous side effects. As a result, “The US Food and Drug Administration placed clinical development of pritelivir on hold in May 2013 (during a phase 2 study).” (2) Dr. Anna Wald, MD, MPH, from the University of Washington wrote that the FDA’s decision was due to the “unexplained dermal and hematologic findings in a toxicology study of monkeys.” (2) The Center for the Biology of Chronic Disease (CBCD) believes that since new drugs against the herpes virus may take some time to reach the market, infected individuals should take Novirin and Gene-Eden-VIR, which are two natural, safe and effective, HSV-2 remedies that are backed by clinical studies.
Click to learn more about genital herpes symptoms.
The formula of Novirin and Gene-Eden-VIR was tested by Hanan Polansky and Edan Itzkovitz from the CBCD in two clinical studies that followed FDA guidelines. The studies showed that the Novirin and Gene-Eden-VIR formula is effective against the herpes simplex virus, and other viruses. The clinical studies were published in the peer reviewed, medical journal Pharmacology & Pharmacy, the first, in a special edition on Advances in Antiviral Drugs. Study authors wrote that, “individuals infected with the HSV … reported a safe decrease in their symptoms following treatment with Gene-Eden-VIR.” (3) The study authors also wrote that, “we observed a statistically significant decrease in the severity, duration, and frequency of symptoms.” (3)
Novirin and Gene-Eden-VIR are natural antiviral dietary supplements. Their formula contains five natural ingredients: Selenium, Camellia Sinesis Extract, Quercetin, Cinnamomum Extract, and Licorice Extract. The first ingredient is a trace element, and the other four are plant extracts. Each ingredient and its dose was chosen through a scientific approach. Scientists at polyDNA, the company that invented and patented the formula, scanned thousands of scientific and medical papers published in various medical and scientific journals, and identified the safest and most effective natural ingredients against latent viruses. To date, Novirin and Gene-Eden-VIR are the only natural antiviral products on the market with published clinical studies that support their claims.
Until now, drugs approved for the treatment of HSV-2 infections include penciclovir, acyclovir, famciclovir, and valaciclovir. However, their effectiveness is limited. For instance, “a meta-analysis of five placebo-controlled and two dose comparison studies evaluated the effect of aciclovir, famciclovir or valaciclovir on symptoms. The meta-analysis showed that oral antiviral therapy decreases the duration and the associated pain of an outbreak by merely one day.” (3) There are also natural remedies that target the latent HSV. Two of these clinically backed remedies are Novirin and Gene-Eden-VIR.
The CDC notes that “Genital herpes is common in the United States. In the United States, about one out of every six people aged 14 to 49 years have genital herpes. You can get herpes by having vaginal, anal, or oral sex with someone who has the disease. Fluids found in a herpes sore carry the virus, and contact with those fluids can cause infection. You can also get herpes from an infected sex partner who does not have a visible sore or who may not know he or she is infected because the virus can be released through your skin and spread the infection to your sex partner(s).” (4)
“Research shows that most drugs against HSV-2 only reduce outbreaks by one day. Thus, we recommend that infected individuals take Novirin or Gene-Eden-VIR, which are designed to help the immune system target the latent HSV-2.” – Greg Bennett, CBCD
(1) Sciencenews.org – Seppa, N. Experimental herpes drug outperforms first-line med. Published September 11, 2014.
(2) Medscape.com – Hand, L. Pritelivir May Be Effective and Safe Against Genital Herpes. Published January 16, 2014.
(3) Polansky, H. Itzkovitz, E. Gene-Eden-VIR Is Antiviral: Results of a Post Marketing Clinical Study. Published in September 2013.
(4) CDC.com – Genital Herpes – CDC Fact Sheet. Last updated on July 1, 2014.
The Center for the Biology of Chronic Disease (http://www.cbcd.net) is a not-for-profit tax-exempt organization under section 501(c) 3 of the IRS tax code. The center’s mission is to advance the research on the biology of chronic disease and to accelerate the discovery of a cure for these diseases. The CBCD first published Dr. Hanan Polansky’s highly acclaimed “Purple” book, entitled “Microcompetition with Foreign DNA and the Origin of Chronic Disease” in 2003. In this book, he explains how foreign DNA fragments can cause many major diseases. The book has been read by more than 5,000 scientists around the world, and has been reviewed in more than 20 leading scientific journals. These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.